Robin A, Owen C, Perry S, Street L, et al. Efficacy and Safety of Bendamustine-Rituximab for Nodular Lymphocyte Predominant Hodgkin Lymphoma. Eur J Haematol 2025 Jun 1. doi: 10.1111/ejh.14443.
PMID: 40451625